Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MISHA Post-Market Clinical Study

NCT: NCT06118892 · RECRUITING

NCT IDNCT06118892
StatusRECRUITING
Start Date2023-11-03
Completion2030-07-30

Brief Summary

Prospective evaluation of the safety and effectiveness of the MISHA Knee System. The study will collect data on the procedural and long-term adverse events, WOMAC pain and function scores, KSS satisfaction, subsequent surgical interventions, BMI levels, range of motion, UCLA activity level of the subjects, and perform radiographic/x-ray evaluations at clinical visits through 5 years post-procedure. The primary analysis of this study is freedom from device- and procedure-related SSIs at five (5) years post-implantation. This study will also assess device performance in subjects with intact and retained devices and subjects with devices removed prior to study termination and freedom from conversion to arthroplasty through 5 years. Study subjects will be followed over a five-year post-implant period.

Frequently Asked Questions

What is MISHA Post-Market Clinical Study?

MISHA Post-Market Clinical Study is a clinical trial registered under NCT06118892. Current status: RECRUITING.

What is the status of NCT06118892?

The current status of NCT06118892 (MISHA Post-Market Clinical Study) is: RECRUITING.

When did MISHA Post-Market Clinical Study start?

MISHA Post-Market Clinical Study started on 2023-11-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.